Renal adverse effect of intravenous administration of iodixanol (270mg I/ml)

Jing-yun WU,Xiao-ying WANG,Bao-cui ZHANG
DOI: https://doi.org/10.13609/j.cnki.1000-0313.2014.03.006
2014-01-01
Abstract:Objective:To study the adverse effects of iodixanol on renal function of patients.Methods:Totally 432inpatients undergone coronary CTA examination were retrospectively analyzed.The patients were divided into two groups: iso-osmolar contrast media group(IO group),115cases,using iodixanol(270mg I/ml),and low-osmolar contrast media group(LO group),317cases,using iopamidol(370mg I/ml).One hundred and ten in-patients undergone unenhanced CT were recruited as control group.The clinical features,changes of plasma Scr and eGFR(estimated glomerular filtration rate),incidence of CIN(contrast-induced nephropathy)were compared and analyzed.Results:No serious acute adverse events were recorded.The average age of IO group was much smaller than that of LO group and control group(P0.017). No statistically difference was found in sex constituent ratio between these three groups.There were more patients with risk factors in IO group than in the other two groups(P0.017),and more patients with risk factors in LO group than in control group(P0.017).The plasma Scr deceased and eGFR increased in IO group(P0.05).The plasma Scr increased in LO group(P0.05).The plasma Scr and eGFR showed no statistically significant difference before and after unenhanced examination.Incidence of CIN:the incidence of in IO group and LO group was 2.6%and 7.9%,respectively.13.6%of patients in control group met the definition of with increased Scr after unenhanced CT examination.The incidence of in IO group is much lower than that of control group(P0.017).There was no statistically significant difference in incidence of between IO group and LO group,as well as between LO group and control group.Conclusion:There is no adverse effect on renal function in IO group,while there is increase of Scr in LO group.The incidence of in IO group is close to that in LO group.The increase of Scr could be observed in patients without contrast media administration,so the judgment of CIN should be cautious,with careful discrimination of other factors of renal function impairment.
What problem does this paper attempt to address?